Herspiegel Acquires Decisive Consulting to Boost Global Life Sciences Commercialization
Deal News | Jun 23, 2025 | PR Newswire Cision Herspiegel Consulting
Herspiegel, a firm known for pharmaceutical commercialization, has acquired Decisive Consulting to bolster its global influence in life sciences. This strategic move melds Decisive’s market-focused 'Rebel Thinking' approach with Herspiegel’s renowned U.S. commercialization expertise. With the recent acquisition of FIECON's HEOR and HTA expertise, the combined forces of Herspiegel now offer comprehensive services across the product lifecycle, from early asset strategy to market optimization. Esther Nzenza, CEO of Decisive, will remain a key figure at Herspiegel, ensuring that the integrated group continues to deliver strategic insights and operational excellence. This expansion is aimed at improving patient access to therapies globally, leveraging a synergy of scientific insight and market strategy to lead in the life sciences industry.
Sectors
- Pharmaceutical & Life Sciences
- Consulting Services
Geography
- United States – Herspiegel is based in Yardley, Pennsylvania, and has a strong influence in the U.S. market, which plays a key role in the acquisition.
- United Kingdom – Decisive Consulting is headquartered in London, indicating a significant market presence in the UK, which is instrumental in their international strategy following the acquisition.
Industry
- Pharmaceutical & Life Sciences – The acquisition directly involves companies that operate within the pharmaceutical and life sciences sectors, focusing on commercialization, market access, and strategic consultancy.
- Consulting Services – Both Herspiegel and Decisive Consulting are engaged in providing consulting services specifically tailored to the life sciences industry, offering expertise in strategy, evidence, and market access.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Herspiegel | Acquiring Company | Company | A leader in pharmaceutical commercialization consulting focused on maximizing brand potential and patient access to therapies. |
| Decisive Consulting | Target Company | Company | A consulting firm known for its innovative market access strategies in the life sciences industry, challenging conventional approaches. |
| Esther Nzenza | CEO and Founder of Decisive Consulting | Person | Founder of Decisive Consulting, she will continue as a Senior Partner at Herspiegel, focusing on global value and market access strategies. |
| Brent Herspiegel | CEO of Herspiegel | Person | CEO of Herspiegel, leading the strategic expansion and integration efforts post-acquisition. |